Diagnostic Value of ADA Multiplied by Lymphocyte to Neutrophil Ratio in Tuberculous Pleurisy

결핵성 흉막염에서 ADA 활성도와 림프구/중성구 비의 곱의 진단적 유용성

  • Jeon, Eun Ju (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Kwak, Hee Won (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Song, Ju Han (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Lee, Young Woo (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Jeong, Jae Woo (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Choi, Jae Cheol (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Shin, Jong Wook (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Kim, Jae Yeol (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Park, In Won (Department of Internal Medicine, Chung Ang University College of Medicine) ;
  • Choi, Byoung Whui (Department of Internal Medicine, Chung Ang University College of Medicine)
  • 전은주 (중앙대학교 의과대학 내과학교실) ;
  • 곽희원 (중앙대학교 의과대학 내과학교실) ;
  • 송주한 (중앙대학교 의과대학 내과학교실) ;
  • 이영우 (중앙대학교 의과대학 내과학교실) ;
  • 정재우 (중앙대학교 의과대학 내과학교실) ;
  • 최재철 (중앙대학교 의과대학 내과학교실) ;
  • 신종욱 (중앙대학교 의과대학 내과학교실) ;
  • 김재열 (중앙대학교 의과대학 내과학교실) ;
  • 박인원 (중앙대학교 의과대학 내과학교실) ;
  • 최병휘 (중앙대학교 의과대학 내과학교실)
  • Received : 2007.05.11
  • Accepted : 2007.06.13
  • Published : 2007.07.30

Abstract

Background: Many diagnostic approaches for defining the definitive cause of pleurisy should be included due to the large variety of diseases resulting in pleural effusion. Although ADA is a useful diagnostic tool for making a differential diagnosis of pleural effusion, particularly for tuberculous pleural effusion, a definitive diagnostic cut-off value remains problematic in Korea. It was hypothesized that ADA multiplied by the Lymphocyte/Neutrophil ratio(L/N ratio) might be more powerful for making a differential diagnosis of pleural effusion. Methods: One hundred and ninety patients, who underwent thoracentesis and treatment in Chung-Ang University Hospital from January, 2005 through to February 2006, were evaluated. The clinical characteristics, radiologic data and the examination of the pleural effusion were analyzed retrospectively. Results: 1. Among the 190 patients, 59 patients (31.1%) were diagnosed with tuberculous pleurisy, 45 patients(23.7%) with parapneumonic effusion, 42 patients(22.1%) with malignant effusions, 36 patients(18.9%) with transudate, and 8 patients(4.2%) with empyema. One hundred and twenty one patients were found to have an ADA activity of 1 to 39 IU/L(63.7%). Twenty-nine were found to have an ADA activity of 40 to 75 IU/L(15.3%) and 40 were found to have an ADA activity of 75 IU/L or greater(21.0%). 2. Among the patients with tuberculous pleurisy, 5(8%), 18(30%) and 36 patients(60%) had an ADA activity ranging from 1 to 39 IU/L, 40 to 75 IU/L, and 75 IU/L or greater, respectively. In those with an ADA activitiy 40 to 75 IU/L, 18 patients(62%) had tuberculous pleurisy, 9(31%) had parapneumonic effusion and empyema, and 1(3.4%) had a malignant effusion. 3. In those with an ADA activity of 40 to 75 IU/L, there was no significant difference between tuberculous pleurisy and non-tuberculous pleural effusion(tuberculous pleurisy : 61.3 ${\pm}$ 9.2 IU/L, non-tuberculous pleural effusion : 53.3${\pm}$10.5 IU/L). 4. The mean L/N ratio of those with tuberculous pleurisy was 39.1 ${\pm}$ 44.6, which was significantly higher than nontuberculous pleural effusion patients (p<0.05). The mean ADA x L/N ratio of the tuberculous pleurisy patients was 2,445.7 ${\pm}$ 2,818.5, which was significantly higher than the non-tuberculous pleural effusion patients (level p<0.05). 5. ROC analysis showed that the ADA x L/N ratio had a higher diagnostic value than the ADA alone in the group with an ADA between 40-75 IU/L. Conclusion: The ADA multiplied by the lymphocyte-to-neutrophil ratio might provide a more definitive diagnosis of tuberculous pleurisy.

배경 및 목적: 흉수의 원인은 매우 다양한 만큼 진단에 많은 검사방법이 이용되고 있다. Adenosine Deaminase(ADA)의 활성도는 결핵성 흉수 저류의 진단에 유용한 검사법의 하나로 알려져 있다. ADA의 수치가 높을 수록 결핵을 진단하는 데 더욱 유용하지만, 양성기준을 정하는 데 아직 확정적이지 못하다. 이에 본 연구에서는 ADA와 함께 림프구/중성구 비를 동시에 진단에 적용하였을 때 진단적 가치를 알아보고자 하였다. 방 법: 2005년 1월부터 2006년 2월까지 중앙대학교병원 및 중앙대학교 용산병원에 흉수 저류로 입원하여 진단적 흉수 천자 및 치료를 받은 190명의 환자를 대상으로 하여, 임상 특성과 영상의학적 자료 및 흉수액에 대한 자료를 후향적으로 조사하였다. 결 과: 1) 190명의 원인으로 결핵이 59명(31.1%)이었으며, 부폐렴성 흉막염 45명(23.7%), 악성 흉수 저류 42명(22.1%), 여출액 36명(18.9%), 농흉 8명(4.2%)이었다. ADA 활성도가 1-39 IU/L인 경우가 121 명(63.7%)이었고, 40-75 IU/L 범위에는 29명(15.3%), 75 IU/L를 초과한 경우가 40명(21.0%)이었다. 2) 결핵은 ADA 활성도가 1-39 IU/L인 경우가 5명(8%)이었고, 40-75 IU/L 범위에는 18명(30%), 75 IU/L를 초과한 경우가 36명(60.0%)이었다. ADA가 40-75IU/L사이일 때, 결핵은 18명(62%), 부폐렴성 흉막염 및 농흉은 9명(31%)이었고 악성 흉수염은 1명이었다. ADA 활성도가 40-75 IU/L인 범위 내에서는 결핵성 흉막염(ADA=61.3${\pm}$9.2 IU/L)과 나머지 질환(ADA=53.3${\pm}$10.5 IU/L)에서 ADA의 평균의 차이가 나지 않았다. 3) 림프구/호중구의 비는 결핵성 흉막염은 39.2${\pm}$ 44.6, 비결핵성은 0.2${\pm}$0.2 로 유의한 차이를 보였다. (ADA X 림프구/호중구)의 값은 결핵성 흉막염은 2,445.7${\pm}$2,818.5 IU/L, 비결핵성은 10.6${\pm}$11.3 IU/L으로 매우 큰 차이를 보이는 것을 관찰할 수 있었다. 그리고, ROC 분석을 하였을 때 ADA보다 민감도와 특이도가 유의하게 증가되었다. 결 론: ADA만으로 결핵성 흉수 저류를 진단하기 어려울 때, 림프구/호중구비와 ADA를 곱한 값은 결핵성 흉막염의 더 정확한 감별진단에 도움을 줄 수 있을 것으로 보인다.

Keywords

References

  1. Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973;63:8S-92 https://doi.org/10.1378/chest.63.4_Supplement.38S
  2. Jay SJ. Diagnostic procedures for pleural disease. Clin Chest Med 1985;6:33-48
  3. Piras MA, Gakis C, Budroni M, and Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J 1978;2:1571-2
  4. Maritz FJ, Malan C, Le Roux I. Adenosine deaminase estination in the differentiation of pleural effusions. S Afr Med J 1982;62:556-8
  5. Ocana I, Martinez-Vazquez JM, Segura RM, FernandezDe- Sevilla T, Capdevila JA. Adenosine deaminase in pleural fluids: test for diagnosis of tuberculous pleural effusion. Chest 1983;84:51-3 https://doi.org/10.1378/chest.84.1.51
  6. Banales JL, Pineda PR, Fitzgerald JlV- Rubio H, Selman M, Salazar-Lezama M Adenosine deaminase in the diagnosis of tuberculous pleural effusions: a report of 218 patients and review of the literature. Chest 1991;99:355-7 https://doi.org/10.1378/chest.99.2.355
  7. San Jose E, Valdes L, Sarandeses A, Alvarez D, Chomon B. Diagnostic value of adenosine deaminase and lysozyme in tuberculous pleurisy. Clin Chim Acta 1992;200:73-81 https://doi.org/10.1016/0009-8981(91)90079-R
  8. Strankinga WF, Nauta JJ, Straub JP, Stam J. Adenosine deaminase activity in tuberculous pleural effusions: a diagnostic test. Tubercle 1987;68:137-40 https://doi.org/10.1016/0041-3879(87)90029-8
  9. Valdes L, San Jose E, Alvarez D, Sarandeses A, Pose A, Chomon B, et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme, and interferon gamma. Chest 1993;103: 458-65 https://doi.org/10.1378/chest.103.2.458
  10. Pettersson T, Ojala K, Weber TH Adenosine deaminase in the diagnosis of pleural effusions. Acta Med Scand 1984;215:299-304 https://doi.org/10.1111/j.0954-6820.1984.tb05011.x
  11. Van Keimpema AR, Slaats EH, Wagenaar JP. Adenosine deaminase activity, not diagnostic for tuberculous pleurisy. Eur J Respir Dis 1987;71:15-8
  12. Maartens G, Bateman ED. Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax 1991;46:96-9 https://doi.org/10.1136/thx.46.2.96
  13. Antony VB, Godbey SW, Kunkel SL, Hott JW, Hartman DL, Burdick MD, et al. Recruitment of inflammatory cells to the pleural space: chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 1993;151:7216-23
  14. Saks AM, Posner R, Tuberculosis in HIV positive patients in South Africa: a comparative radiological study with HlV negative patients. Clin Radiol 1992;46:387-90 https://doi.org/10.1016/S0009-9260(05)80684-1
  15. Van der Weyden MB, Kelley WN. Human adenosine deaminase. Distribution and properties. J Biol Chem 1976;251:5448-56
  16. Barton RW, Goldschneider I. Nucleotide-metabolizing enzymes and lymphocyte differentiation. Mol Cell Biochem 1979;28:135-47
  17. Shore A, Thsch HM, Gelfand EW. Role of adenosine deaminase in the early stages of T cell maturation. Clin Exp Immunol 1981;44:152-5
  18. Fischer D, van der Weyden MB, Snyderman R, Kelley WN. A role for adenosine deaminase in human monocyte maturation. J Clin Invest 1976;58:399-407 https://doi.org/10.1172/JCI108484
  19. Light R. Parapneumonic effusions and infections of the pleural space. In: Light RW, ed. Pleural disease. 2nd ed. Philadelphia: Lea & Febiger; 1990. p. 129-49
  20. Sahn SA. State of the Art: the pleura. Am Rev Respir Dis 1988;138:184-234 https://doi.org/10.1164/ajrccm/138.1.184
  21. Light RW, Erozan YS, Ball WC. Cells in pleural fluid: their value in differential diagnosis. Arch Intern Med 1973;132:854-60 https://doi.org/10.1001/archinte.132.6.854
  22. Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967;66:972-82 https://doi.org/10.7326/0003-4819-66-5-972
  23. Bovornkitti S, Pushpakom R, Maranetra N, Nana A, Charoenratanakul S. Adenosine deaminase and lymphocytic populations. Chest 1991;99:789-90
  24. Baganha MF, Pego A, Lima MA, Gaspar EV, Cordeiro AR Serum and pleural adenosine deaminase: correlation with lymphocytic populations. Chest 1990;97:605-10 https://doi.org/10.1378/chest.97.3.605
  25. de Wit D, Maartens G, Steyn L. A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion. Tuber Lung Dis 1992;73:262-7 https://doi.org/10.1016/0962-8479(92)90130-C